Selection from HEOR Bibliography
| Search criteria | ||||
| Korea |
||||
| Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study | ||||
| Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group | ||||
| "1 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 2 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 3 Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea 4 Kansai Electric Power Medical Research Institute, Kobe, Japan 5 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 6 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 7 Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 8 Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan 9 National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan 10 Department of Cardiovascular Medicine, Saga University, Saga, Japan 11 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 12 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan 13 Boehringer Ingelheim Korea Ltd, Seoul, Korea 14 IQVIA, Espoo, Finland 15 Boehringer Ingelheim International GmbH, Ingelheim, Germany 16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA 17 Kansai Electric Power Hospital, Osaka, Japan " | ||||
| "JDI journal Virtual Conference: ACC, May 2021" |
||||
| , Article | ||||
| , Japan, Korea, Taiwan | ||||
| Abstract: https://doi.org/10.1111/jdi.13959 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study | 2023 | English | , Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis | |
| Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) | ||||
| Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas | ||||
| University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States | ||||
| , Article | ||||
| , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA | ||||
| Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446 | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2021 | English | , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study | |
| Benzodiazepine prescribing in the elderly in Germany and Korea: A comparison of two observational studies
. | ||||
| Woodcock BG, Kostev K, Shin JY | ||||
| Int J Clin Pharmacol Ther. 2017 May 10. doi: 10.5414/CP203042. [Epub ahead of print] |
||||
| , Article | ||||
| , Germany, Korea | ||||
| Condition | Year | Language | Analysis type | |
| , Mental health | 2017 | English | , Observational study | |
| Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study. | ||||
| Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
| 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
| ISPOR Europe 2013 Annual meeting |
||||
| , Poster | ||||
| , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2013 | English | , Retrospective database analysis | |
| Current situation of oral anticancer treatments use in France: the ACTOR Study. | ||||
| Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
| 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
| ISPOR Europe 2013 Annual meeting |
||||
| , Abstract | ||||
| , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2013 | English | ||
| Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study. | ||||
| Do-Youn OH 1, Bruce CRAWFORD6, Sung-Bae KIM 2, Hyun-Cheol CHUNG 3, Jeffrey MCDONALD 6, Sang Yoon LEE 4, Su-Kyoung KO4 andJungsil RO 5 | ||||
| 1 Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine 2 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine 3 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System 4 Pfizer Korea, Seoul 5 Center for Breast Cancer, National Cancer Center, Goyang, Korea 6 Adelphi Values, Tokyo, Japa | ||||
| Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. doi: 10.1111/j.1743-7563.2012.01546.x. Epub 2012 May 21. |
||||
| , Article | ||||
| , Korea | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22898238 | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2012 | English | , Burden of illness, Survey research | |
| Cost-Effectiveness Of Rivaroxaban Versus Enoxaparin For Prophylaxis After Total Hip Or Total Knee Replacement In Korea | ||||
| Kim J1, Pollock R2, Jung S3, Diamantopoulos A4, Lees M5 | ||||
| 1IMS Health, Seoul, South Korea, 2IMS Health, Basel, Switzerland, 3Bayer Korea, Seoul, South Korea, 4IMS Health, London, UK, 5Bayer HealthCare, Uxbridge, UK | ||||
| ISPOR 14th Annual International Meeting, Orlando, Florida, USA May 16-20, 2009 |
||||
| , Poster | ||||
| , Korea | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2009 | English | , Cost effectiveness | |
| An economic evaluation of drospirenone 2 mg/estradiol 1.033 mg versus tibolone 2.5mg in the treatment of postmenopausal women with grade 1 or 2 hypertension in Korea | ||||
| Jung S1, Watson P2, Asukai Y3, Jeong M4 | ||||
| 1 Bayer Korea, Seoul, South Korea 2 IMS Health, London, UK | ||||
| ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France |
||||
| , Poster | ||||
| , Korea | ||||
| Condition | Year | Language | Analysis type | |
| , Womens Health | 2009 | English | , , Economic evaluation | |